Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

康臣 - NMPA Drug Approval Details

Approvals/NMPA/Cetirizine Hydrochloride Oral Solution

Approved

化学药品

Cetirizine Hydrochloride Oral Solution

广州康臣药业有限公司;康臣药业(内蒙古)有限责任公司🇨🇳 National Medical Products Administration

Approval Date: Mar 9, 2020
Approval ID: 7LeaeXnb7ef
Company: 广州康臣药业有限公司;康臣药业(内蒙古)有限责任公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeXnb7ef
Approval Number: 国药准字H20000155
Generic Name: 盐酸西替利嗪口服溶液
Generic Name En: Cetirizine Hydrochloride Oral Solution
Brand Name: 康臣
Drug Type: 化学药品
Dosage Form: 口服溶液剂
Strength: 10ml:10mg
Reg Date: 2020-03-09
Company Name: 广州康臣药业有限公司;康臣药业(内蒙古)有限责任公司
Production Company Name: 广州康臣药业有限公司;康臣药业(内蒙古)有限责任公司
Production Company Address: 广州经济技术开发区东区东鹏大道71号；通辽市科左后旗甘旗卡镇

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 9, 2020

Approval ID

7LeaeXnb7ef

Type

化学药品

Back to NMPA Approvals